|
Jan 10
|
Nevro laying off 63 people to strengthen financial position
|
|
Jan 9
|
Nevro Announces Preliminary Fourth-Quarter and Full-Year 2023 Revenue Results
|
|
Jan 4
|
Nevro to Present at 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 26
|
3 Reasons to Retain Nevro (NVRO) in Your Portfolio for Now
|
|
Dec 7
|
Inogen (INGN) Down 4.2% Since Last Earnings Report: Can It Rebound?
|
|
Dec 5
|
What's in Store for Cooper Companies (COO) in Q4 Earnings?
|
|
Dec 4
|
Nevro buys low back pain company Vyrsa for $40M
|
|
Dec 1
|
Nevro (NVRO) Up 15.7% Since Last Earnings Report: Can It Continue?
|
|
Dec 1
|
Nevro's (NVRO) Latest Buyout to Boost SI Joint Pain Treatment
|
|
Nov 30
|
Nevro Announces Acquisition of Vyrsa™ Technologies
|
|
Aug 10
|
Nevro announces launch of HFX Connect™ in Europe and CE marking of expanded labelling for the HFX™ SCS system.
|
|
Apr 27
|
Nevro Corp. Announces New Employment Inducement Grant under Section 303A.08 of the NYSE Listed Company Manual
|
|
Apr 27
|
Nevro (NVRO) Q1 Earnings and Revenues Surpass Estimates
|
|
Apr 27
|
Q1 2023 Nevro Corp Earnings Call
|
|
Apr 26
|
Nevro (NVRO) Reports Q1 Loss, Tops Revenue Estimates
|
|
Apr 26
|
Nevro Reports First Quarter 2023 Financial Results, Provides Second Quarter Guidance and Reiterates Full-Year 2023 Guidance
|
|
Apr 25
|
Ecolab (ECL) to Report Q1 Earnings: What's in the Offing?
|
|
Apr 25
|
MedTech Stocks' Q1 Earnings Due on Apr 26: MMSI, CNMD & More
|
|
Apr 25
|
How Much Upside is Left in Nevro (NVRO)? Wall Street Analysts Think 53.7%
|
|
Apr 24
|
Nevro Announces Enrollment of First Patient in PDN Sensory Study
|